EDN1 overexpression has also been reported in colon cancer (Kim et al. 2005), pancreatic cancer (Gupta et al. 2020), and ovarian cancer (Rosanò et al. 2014). This evidence concerns the gene EDN1 and pancreatic neoplasm.